Nimish Shah Overview

  • Primary Position
  • Board Member

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 1

  • Med. Deal Size

Nimish Shah General Information

Biography

Mr. Nimish Shah serves as Partner, Crossover/Public Healthcare at Venrock. Mr. Shah serves as Board Member at Apogee Therapeutics and Instil Bio. He also serves as the Board Observer at Biohaven Pharmaceutical. He joined Venrock's New York office in 2013 and focuses on a range of healthcare subsectors including generics, specialty pharmaceuticals, biotechnology, and animal health. Most recently, he worked at Citadel and was involved in the firm's healthcare investments. Before Citadel, he was a Research Analyst at Credit Suisse covering the specialty pharma and generics sectors. He began his career as a retail pharmacist and later spent time working in the Medical Affairs department at Novartis. He received his BS in pharmacy with honors from Rutgers College of Pharmacy, MPH from the Mailman School of Public Health at Columbia University, and MBA from Columbia Business School.

Contact Information

Primary Position
Board Member, Apogee Therapeutics
Education
Columbia University, MPH (Masters of Public Health)
Columbia Business School, MBA (Master of Business Administration)
Rutgers University, New Brunswick, BS (Bachelor of Science)
Gender
Male
Email
ns
Phone
+1 (650)
Address
  • 221 Crescent Street
  • Building 17, Suite 102B
  • Waltham, MA 02453
  • United States
+1 (650)

Nimish Shah Positions (1)

Firm name Firm type Title Location Industry Since
Venrock Investor Partner, Crossover/Public Healthcare Palo Alto, CA Venture Capital

Nimish Shah Board Seats (1)

Company Industry Ownership Status Financing Status Location Since
Apogee Therapeutics Biotechnology Publicly Held Formerly VC-backed Waltham, MA

Nimish Shah Lead Partner on Deals (1)

Nimish Shah has been the lead partner on 1 deal. Their latest deal was with Metsera, a drug discovery company. The deal was made for on 13-Nov-2024.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Metsera 13-Nov-2024 Early Stage VC (Series B) Completed Drug Discovery New York, NY

Nimish Shah Network (60)

Board Members (34)

Name Company Representing Location From
Jennifer Fox Apogee Therapeutics Self Waltham, MA
John Childs Biohaven Self Tortola, VI
Biohaven RA Capital Management Tortola, VI
Sojournix Self Waltham, MA
Apogee Therapeutics Self Waltham, MA

Portfolio Executives (10)

Name Company Role Deal date Location
Whit Bernard Metsera Chief Executive Officer 13-Nov-2024 New York, NY
Michael Donovan Metsera Chief Design Officer 13-Nov-2024 New York, NY
Metsera Chief Financial Officer, Finance & Executive 13-Nov-2024 New York, NY
Metsera Chief Experience Officer 13-Nov-2024 New York, NY
Metsera Chief Financial Officer 13-Nov-2024 New York, NY

Fund Team Members (16)

Name Investor Fund Fund Location
David Pakman Venrock Venrock Associates VIII Palo Alto, CA
Colin Cahill Venrock Venrock Associates VIII Palo Alto, CA
Venrock Palo Alto, CA
Venrock Palo Alto, CA
Venrock Palo Alto, CA

Nimish Shah Affiliated Funds (3)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Venrock Healthcare Capital Partners EG Venrock Venture - General Closed 2022
Venrock Healthcare Capital Partners III Venrock Venture Capital - Later Stage Closed 2018
Venrock Associates VIII Venrock Venture Capital - Early Stage Closed 2017

Nimish Shah FAQs

  • Who is Nimish Shah?

    Mr. Nimish Shah serves as Partner, Crossover/Public Healthcare at Venrock.

  • How much does Nimish Shah typically invest?

    Nimish Shah's median deal size is .

  • What is Nimish Shah’s main position?

    Nimish Shah’s primary position is Board Member.

  • What are the contact details for Nimish Shah?

    Nimish Shah’s email address is ns and his phone number is +1 (650) .

  • How many active board seats does Nimish Shah hold?

    Nimish Shah holds a board seat in Apogee Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »